NASDAQ:APLT
Delisted

Applied Therapeutics Stock Insider Trading

etoro logo Buy APLT
*Your capital is at risk
$0.0959
+0 (+0%)
At Close: Apr 28, 2026

Applied Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -62.33. In total, the insiders bought 12.37M and sold 10.56M APLT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-62.33
Buy 12.37M shares
Sell 10.56M shares
44% Buy Activity
Moderate Negative Correlation
Sell Signal High Confidence
Feb 03, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -62.33.
  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Dec 19, 2024
Buy
Common Stock
A-Award
Johnson John
Executive Chairman
CEO / President 500 000
Value: $510.0K
Dec 19, 2024
Buy
Stock Option (Right to Buy)
A-Award
Johnson John
Executive Chairman
CEO / President 1 000 000
Value: $1.02M
Aug 22, 2024
Sell
Common Stock
S-Sale
Funtleyder Leslie D.
Chief Financial Officer
C-Suite Officer 13 530
Value: $78.9K
Aug 22, 2024
Sell
Common Stock
S-Sale
Perfetti Riccardo
Chief Medical Officer
Officer 22 681
Value: $132.2K
Aug 22, 2024
Sell
Common Stock
S-Sale
Perfetti Riccardo
Chief Medical Officer
Officer 22 681
Value: $132.2K
Aug 22, 2024
Sell
Common Stock
S-Sale
Funtleyder Leslie D.
Chief Financial Officer
C-Suite Officer 13 530
Value: $78.9K
Aug 14, 2024
Sell
Common Stock
S-Sale
Shendelman Shoshana
President And CEO
CEO / President 119 591
Value: $709.2K
Aug 14, 2024
Sell
Common Stock
S-Sale
Shendelman Shoshana
President And CEO
CEO / President 119 591
Value: $709.2K
Aug 13, 2024
Sell
Common Stock
S-Sale
Shendelman Shoshana
President And CEO
CEO / President 357 423
Value: $2.21M
Aug 13, 2024
Sell
Common Stock
S-Sale
Shendelman Shoshana
President And CEO
CEO / President 357 423
Value: $2.21M
Aug 12, 2024
Sell
Common Stock
S-Sale
Shendelman Shoshana
President And CEO
CEO / President 300 000
Value: $1.79M
Aug 12, 2024
Sell
Common Stock
S-Sale
Shendelman Shoshana
President And CEO
CEO / President 300 000
Value: $1.79M
Aug 05, 2024
Buy
Common Stock
G-Gift
Shendelman Shoshana
President And CEO
CEO / President 747 886
Value: $4.49M
Aug 05, 2024
Sell
Common Stock
G-Gift
Shendelman Shoshana
President And CEO
CEO / President 747 886
Value: $0
Aug 05, 2024
Sell
Common Stock
G-Gift
Shendelman Shoshana
President And CEO
CEO / President 747 886
Value: $0
Aug 05, 2024
Buy
Common Stock
G-Gift
Shendelman Shoshana
President And CEO
CEO / President 747 886
Value: $4.49M
Jun 06, 2024
Sell
Common Stock
S-Sale
Shendelman Shoshana
President And CEO
CEO / President 61 795
Value: $267.0K
Jun 06, 2024
Sell
Common Stock
S-Sale
Perfetti Riccardo
Chief Medical Officer
Officer 22 003
Value: $95.1K
Jun 06, 2024
Sell
Common Stock
S-Sale
Funtleyder Leslie D.
Chief Financial Officer
C-Suite Officer 16 980
Value: $73.4K
Jun 06, 2024
Sell
Common Stock
S-Sale
Funtleyder Leslie D.
Chief Financial Officer
C-Suite Officer 16 980
Value: $73.4K
Jun 06, 2024
Sell
Common Stock
S-Sale
Perfetti Riccardo
Chief Medical Officer
Officer 22 003
Value: $95.1K
Jun 06, 2024
Sell
Common Stock
S-Sale
Shendelman Shoshana
President And CEO
CEO / President 61 795
Value: $267.0K
Jun 06, 2024
Buy
Common Stock
A-Award
Lerner Teena
Director
Director 45 000
Value: $202.5K
Jun 06, 2024
Buy
Common Stock
A-Award
Marcus Joel S
Director
Director 45 000
Value: $202.5K
Jun 06, 2024
Buy
Common Stock
A-Award
Skyler Jay S
Director
Director 45 000
Value: $202.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT APPLIED THERAPEUTICS INC.
Applied Therapeutics
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE